The biological effects of low-dose radiation are not only of social concern but also of scientific interest. The radioadaptive response, which is defined as an increased radioresistance by prior exposure to low-dose radiation, has been extensively studied both in vitro and in vivo. Here we briefly review the radioadaptive response with respect to mutagenesis, survival rate, and carcinogenesis in vivo, and introduce our recent findings of cross adaptation in mouse thymic cells, that is, the suppressive effect of repeated low-dose radiation on mutation induction by the alkylating agent N-ethyl-N-nitrosourea.
INTRODUCTION
Most radiation protection authorities adopt the 'linear nothreshold hypothesis', which assumes that any radiation dose, no matter how low, has the potential to increase cancer risk and heritable mutations. Several experiments both in vitro and in vivo have demonstrated the radioadaptive response from low-dose radiation exposure and from chronic low dose-rate radiation exposure for either spontaneous mutations or a subsequent challenge with high-dose radiation, and therefore do not always appear to support this hypothesis. [1] [2] [3] We here present a brief review of the radioadaptive response after whole-body exposure, and we introduce our recent results regarding cross adaptation, which is defined as decreased cell sensitivity to other mutagenic agents after pre-exposure to low-dose irradiation.
RADIOADAPTIVE RESPONSE IN VITRO
Olivieri et al. first documented the radioadaptive response. 1) When human lymphocytes were cultured with [ 3 H]thymidine-which acts as a source of low-level chronic radiation-and then exposed to 1.5 Gy of X-rays, the yield of chromatid aberrations was significantly lower than the sum of the yield by both the effects of beta-rays from [ 3 H] (tritium) and X-rays. Many subsequent studies have reported the radioadaptive response using numerous cell lines and various endpoints such as chromosome aberration, mutation, and micronucleus formation. [3] [4] [5] However, the adaptive response varies among cell lines.
6) The radioadaptive response has been also demonstrated for in vitro transformation. Exposure of C3H 10T1/2 murine cells in vitro at doses of 1-100 mGy reduces the frequency of malignant transformation after a subsequent exposure to 4 Gy. 7) In contrast, Sasaki et al. reported an increase in transformation frequency of adapted mouse cells by a subsequent high dose of radiation. 8) It is thought that DNA double-strand breaks and singlestrand breaks caused by radiation exposure might be responsible for induction of the adaptive response. Effectors for DNA repair, such as poly(ADP-ribose) polymerase (PARP), 9) apurinic/apyrimidinic (AP)-endonuclease, 10) DNA protein kinase (DNA-PK), 11) ERCC5 (XPG), 12) ataxia telangiectasia mutated (ATM), 13) and p53, 14) are required for induction of the radioadaptive response. Furthermore, reactive oxygen and nitrogen species (ROS and RNS) 15) are also reported to be involved in the radioadaptive response. These are extensively reviewed in other articles in this issue. 17) These data suggest that the priming dose induces repair factors for chromosome aberrations. However, the genetic constitution of mouse strains influences their responsiveness.
IN VIVO STUDIES ON CHROMOSOMAL ABERRATIONS

4)
RADIOADAPTIVE RESPONSE WITH RESPECT
TO SURVIVAL RATE Yonezawa et al. reported that the radioadaptive response of 6-week-old mice to pre-irradiation increases the survival rate after a mid-lethal radiation dose (7.75 Gy).
18) They reported two types of radioadaptive responses against a subsequent lethal dose of radiation. One response was observed 2 months after pre-irradiation with 50 mGy, and the other was observed 2 weeks after pre-irradiation with 500 mGy. Therefore, there are two distinct combinations of preirradiation dose and the interval before the challenge dose, as a window, for which the relationship is discontinuous. The radioadaptive response was observed in ICR and C57BL/6 mouse strains but not in BALB/c and C3H strains.
Later, Ito et al. investigated the effect of the radioadaptive response on survival of C57BL/6 mice after irradiation with a relatively low dose.
19) The 8-week-old mice received wholebody challenging irradiation at a mid-lethal dose (5.9 Gy) at various intervals after priming with whole-body irradiation at 50-400 mGy. When 50 mGy was given between 24 hr and 2 weeks before the challenge dose, the adaptive response was observed. The differences between the two studies were the age at which the priming and challenge doses were given and the mouse strains used. These results suggest that further studies are necessary to clarify how the radioadaptive response affects survival rate; one such study must assess the differences in protective factors induced after priming at different ages.
RADIOADAPTIVE RESPONSE IN RADIATION-INDUCED CARCINOGENESIS
The adaptive response to radiation-induced carcinogenesis has been investigated. Bhattacharjee reported that 2-Gy irradiation following multiple low doses for 5 or 10 consecutive days induced T-cell lymphoma in Swiss mice at a much lower frequency than that after 2 Gy alone. 20) Ina et al. showed in C57BL/6 mice that the induction of T-cell lymphoma by whole-body X-irradiation with four doses of 1.8 Gy was reduced when 0.075 Gy was given 6 hr prior to each 1.8-Gy irradiation. 21) Mitchel showed that pre-exposure to 100 mGy given 1 day before 1-Gy exposure delayed the onset of myeloid leukemia in CBA mice. 22) They also demonstrated that a 10-mGy exposure given 1 day prior to 4 Gy resulted in a small regain in latency for lymphomas in cancer-prone Trp53 heterozygous mice. 23) Taken together, delay of the onset and growth of tumors is not a rare phenomenon after exposure to low-dose radiation. These results suggest that the protective factors for tumor induction, chromosomal aberrations, point mutations, and DNA instability might be induced after priming exposure.
RADIOADAPTIVE RESPONSE TO RADIATION AND OTHER AGENTS
Because human cancers are caused mainly by nonradiogenic sources, it is important to examine the adaptive response of low-dose radiation to non-radiogenic agents. Ionizing radiation produces a spectrum of lesions in DNA such as base damage, cross-links, and single-and doublestrand breaks, and therefore is also expected to induce adaptation to DNA damage other than double-strand breaks. Indeed, exposure to 10 mGy of X-rays leads to a decrease in the frequency of chromatid deletions induced by a radiomimetic chemical, bleomycin. 24) Also, experiments with mitomycin C, which induces cross-links in DNA, showed that conditioning pretreatment with [ 3 H]thymidine at 3.7 × 10 3 Bq/ml for 12 hr produced half as many chromatid breaks as expected for mitomycin C treatment alone, suggesting cross adaptation for cross-linking reagents. However, the response to an alkylating agent, methyl methanesulfonate, was completely different. When lymphocytes were exposed to pre-irradiation doses of [ 3 H]thymidine or X-rays (10 mGy) and subsequently challenged with methyl methanesulfonate, a synergistic response of chromatid deletions was observed. 24) Conversely, treatment with the tobacco-specific nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone elicited an adaptive response that eliminated cells bearing radiationinduced double-strand breaks in lungs, a phenomenon considered to be reverse-cross adaptation by this carcinogen against the effect of irradiation.
25)
CROSS-ADAPTIVE RESPONSE TO N-ETHYL-N-
NITROSOUREA (ENU) MUTAGENESIS BY LOW-DOSE X-RAYS IN MOUSE THYMOCYTES
Recently, we examined mutation induction in thymocytes after repeated low-dose X-irradiation (0.2 Gy per week for four consecutive weeks) followed by treatment with ENU, the most potent chemical mutagen known, using gpt-delta mice. 26) Weekly exposure with 1.6-2.0 Gy for 4 weeks is the most effective method to induce T-cell lymphoma in mice. 27) However, exposure to X-rays at 0.2 Gy did not induce lymphoma at all, suggesting that 0.2 Gy is within the threshold dose for lymphomagenesis.
First, B6C3F1 gpt-delta mice were treated with X-rays, ENU or both (Fig. 1) , and their thymic cells were analyzed for the frequency of gpt mutation. 26) It was found that ENU treatment increased the mutant frequency by 10-fold relative to the untreated control. Surprisingly, repeated X-irradiation alone reduced the mutant frequency compared to the control, suggesting its protective effect against spontaneously occurring mutations. The mutant frequency induced by ENU was also suppressed to almost the spontaneous level by prior exposure to repeated low-dose X-rays, indicating cross adaptation (Fig. 2) .
Second, we analyzed the class and site distribution of gpt mutations. Spontaneous mutations predominantly comprise G:C to A:T transitions at both non-CpG and CpG sites. Lowdose X-rays reduced G:C to A:T mutation at CpG sites by 6-fold compared with spontaneous mutations. ENU-induced mutations consisted of G:C to A:T at non-CpG sites, G:C to T:A and A:T to T:A, each of which might have originated from ethylated base damage such as O 6 -ethyl-guanine and O 2 -ethyl-thymidine. Prior exposure to X-rays, again, reduced ENU-induced the G:C to A:T transition and A:T to T:A transversion ( Table 1) . Analysis of the activation of DNA repair enzymes involved in mismatch repair and base excision repair and of O 6 -methylguanine methyltransferase is now being conducted.
The class and site distribution of gpt mutations revealed that ENU-treated thymic cells accumulated several common or hot-spot mutations, suggesting that clonal expansion of mutants occurred. The clonality increased up to 80% in the ENU-treated thymus. When exposed to X-rays (0.2 Gy) beforehand, clonality was dramatically reduced to 25%. Clonality in unirradiated control thymic cells was also apparently reduced by X-ray exposure, although the difference was not statistically significant (Fig. 3) . Clonal   Fig. 1 . Experimental design for gpt mutation analysis of thymic DNA from mice treated with X-rays, ENU or a combination of the two. Mice were exposed to X-rays weekly for 4 weeks. ENU was administered at a concentration of 200 ppm in drinking water. Fig. 2 . Mutant frequency analysis of gpt recovered from thymus DNA from control, irradiated (0.2 Gy × 4), ENU-treated, and irradiated/ENU-treated mice. *P < 0.05, significantly different from control. **P < 0.05, significantly different from ENU. Bars represent mean ± S.D. Fig. 3 . Suppression of mutant clonality induced spontaneously and in ENU-treated mice by repeated irradiation with X-rays (0.2 Gy). *P < 0.05, significantly different from control. **P < 0.05, significantly different from ENU. Bars represent means. expansion of initiated cells is an important step in carcinogenesis. We recently found that repeated 0.2 Gy irradiation suppressed ENU-induced T-cell lymphoma (Kakinuma et al., unpublished). Therefore, it may be plausible to ascribe the delayed onset of spontaneous, radiation-induced, or chemically induced tumors after a small conditioning dose of radiation to, at least in part, the suppression of clonal expansion.
CONCLUSION
The present paper briefly reviews the radioadaptive response with regard to mutagenesis and carcinogenesis after whole-body exposure to a challenge dose of radiation. Notably, low-dose radiation functions in an antagonistic/ protective manner against cell damage under certain circumstances. However, uncertainties remain in many aspects of the radioadaptive response and the underlying mechanism. Moreover, much more information is needed on cross adaptation. Because we are exposed to numerous natural and man-made agents, such as those in food and tobacco, 28) the cancer risk of low-dose ionizing radiation should be assessed in the context of combined exposure to other agents. Cross adaptation and cross sensitization may play a role in modifying the cancer risk caused by environmental factors to which we are exposed in our daily life.
Finally, we would like to emphasize the importance of research regarding the response of epithelial tissues such as breast, lung and colon. Most whole-body exposure experiments have been carried out with hematopoietic cells. It is well established that the dose response for human leukemia is linear quadratic whereas that for mouse T-cell lymphoma has a threshold, suggesting the existence of a mechanism to prevent and repair DNA damage or to remove damaged cells in response to low-dose radiation. On the other hand, solid cancers, rather than leukemias, predominantly determine the lifetime risk of radiation in humans, and their dose response curves fit to the linear no-threshold model, suggesting that a radiation dose, no matter how small, has a cancer risk. Efforts to examine the adaptive response of epithelial tissues to low-dose radiation may provide a more meaningful basis for estimating the risk of low-dose radiation exposure.
